ID
12936
Description
Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00005605
Link
https://clinicaltrials.gov/show/NCT00005605
Keywords
Versions (1)
- 1/6/16 1/6/16 -
Uploaded on
January 6, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Cancer NCT00005605
Eligibility Breast Cancer NCT00005605
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00005605
- StudyEvent: Eligibility
C0699749 (UMLS CUI [1,2])
C0019638 (UMLS CUI [2])
C0677850 (UMLS CUI [1,2])
C0202022 (UMLS CUI [1,2])
C0279752 (UMLS CUI [2,1])
C0337434 (UMLS CUI [2,2])